Meta-analysis of the acute effects of nicotine and smoking on human performance.

Nicotine Psychopharmacology Section, National Institute on Drug Abuse, NIH Intramural Research Program, 251 Bayview Blvd., Baltimore, MD 21224, USA.
Psychopharmacology (Impact Factor: 3.99). 04/2010; 210(4):453-69. DOI: 10.1007/s00213-010-1848-1
Source: PubMed

ABSTRACT Empirical studies indicate that nicotine enhances some aspects of attention and cognition, suggesting a role in the maintenance of tobacco dependence. The purpose of this review was to update the literature since our previous review (Heishman et al. Exp Clin Psychopharmacol 2:345-395, 1994) and to determine which aspects of human performance were most sensitive to the effects of nicotine and smoking.
We conducted a meta-analysis on the outcome measures of 41 double-blind, placebo-controlled laboratory studies published from 1994 to 2008. In all studies, nicotine was administered, and performance was assessed in healthy adult nonsmokers or smokers who were not tobacco-deprived or minimally deprived (<or=2 h).
There were sufficient effect size data to conduct meta-analyses on nine performance domains, including motor abilities, alerting and orienting attention, and episodic and working memory. We found significant positive effects of nicotine or smoking on six domains: fine motor, alerting attention-accuracy and response time (RT), orienting attention-RT, short-term episodic memory-accuracy, and working memory-RT (effect size range = 0.16 to 0.44).
The significant effects of nicotine on motor abilities, attention, and memory likely represent true performance enhancement because they are not confounded by withdrawal relief. The beneficial cognitive effects of nicotine have implications for initiation of smoking and maintenance of tobacco dependence.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nicotine is one of the most widely used and abused legal drugs. Although its pharmacological profile has been extensively investigated in humans and rodents, nicotine CNS action remains poorly understood. The importance of finding evolutionarily conserved signaling pathways, and the need to apply high-throughput in-vivo screens for CNS drug discovery, necessitate novel efficient experimental models for nicotine research. Zebrafish (Danio rerio) are rapidly emerging as an excellent organism for studying drug abuse, neuropharmacology and toxicology, and have recently been applied to testing nicotine. Anxiolytic, rewarding and memory-modulating effects of acute nicotine treatment in zebrafish are consistently reported in the literature. However, while nicotine abuse is more relevant to long-term exposure models, little is known about chronic effects of nicotine on zebrafish behavior. In the present study, chronic 4-day exposure to 1-2 mg/L nicotine mildly increased adult zebrafish shoaling but did not alter baseline cortisol levels. We also found that chronic exposure to nicotine evokes robust anxiogenic behavioral responses in zebrafish tested in the novel tank test paradigm. Generally paralleling clinical and rodent data on anxiogenic effects of chronic nicotine, our study supports the developing utility of zebrafish for nicotine research.
    Pharmacology Biochemistry and Behavior 01/2015; · 2.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tobacco and cannabis are among the most commonly used psychoactive substances worldwide, and are often used in combination. Evidence suggests that tobacco use contributes to an increased likelihood of becoming cannabis dependent and similarly cannabis use promotes transition to more intensive tobacco use. Further, tobacco use threatens cannabis cessation attempts leading to increased and accelerated relapse rates among cigarette smokers. Given that treatment outcomes are far from satisfactory among individuals engaged in both tobacco and cannabis use highlights the need for further exploration of this highly prevalent co-morbidity. Therefore, this review will elucidate putative neurobiological mechanisms responsible for facilitating the link between co-morbid tobacco and cannabis use. We performed an extensive literature search identifying published studies that examined co-morbid tobacco and cannabis use. Evidence of both synergistic and compensatory effects of co-morbid tobacco and cannabis use have been identified. Following, co-morbid use of these substances will be discussed within the context of two popular theories of addiction: the addiction vulnerability hypothesis and the gateway hypothesis. Lastly, common route of administration is proposed as a facilitator for co-morbid use. While, only a paucity of treatment studies addressing co-morbid tobacco and cannabis use have been conducted, emerging evidence suggests that simultaneously quitting both tobacco and cannabis may yield benefits at both the psychological and neurobiological level. More research is needed to confirm this intervention strategy and future studies should consider employing prospective systematic designs. (Am J Addict 2015;XX:XX-XX). © American Academy of Addiction Psychiatry.
    American Journal on Addictions 02/2015; · 1.74 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Research examining the relationship between acute nicotine use and experimental measures of risk-taking has yielded conflicting results. The present study sought to expand upon research investigating the acute impact of nicotine on risky choice among non-smokers while measuring and controlling for gender, a potentially confounding variable. Utilizing a between-group, double-blind, experimental design, 69 participants were randomly assigned to one of three conditions (placebo, 2 mg, or 4 mg nicotine gum). Participants completed two behavioral risk-taking measures and a motor control task. Individuals in the nicotine conditions demonstrated a main effect of decreased risk-taking on one measure. An interaction between nicotine, gender and risk-taking was found on the second measure of risk-taking, with only males showing decreased risk-taking in higher nicotine conditions. Results suggest nicotine has an acute effect on non-smokers’ patterns of risk-taking, and provide direction for further research on differential effects of nicotine on risk-taking tasks.
    The Psychological record 06/2014; 64(2):151-159. · 0.96 Impact Factor


Available from